Abstract

In order to develop precision or personalized medicine, identifying new quantitative imaging markers and building machine learning models to predict cancer risk and prognosis has been attracting broad research interest recently. Most of these research approaches use the similar concepts of the conventional computer-aided detection schemes of medical images, which include steps in detecting and segmenting suspicious regions or tumors, followed by training machine learning models based on the fusion of multiple image features computed from the segmented regions or tumors. However, due to the heterogeneity and boundary fuzziness of the suspicious regions or tumors, segmenting subtle regions is often difficult and unreliable. Additionally, ignoring global and/or background parenchymal tissue characteristics may also be a limitation of the conventional approaches. In our recent studies, we investigated the feasibility of developing new computer-aided schemes implemented with the machine learning models that are trained by global image features to predict cancer risk and prognosis. We trained and tested several models using images obtained from full-field digital mammography, magnetic resonance imaging, and computed tomography of breast, lung, and ovarian cancers. Study results showed that many of these new models yielded higher performance than other approaches used in current clinical practice. Furthermore, the computed global image features also contain complementary information from the features computed from the segmented regions or tumors in predicting cancer prognosis. Therefore, the global image features can be used alone to develop new case-based prediction models or can be added to current tumor-based models to increase their discriminatory power.

Highlights

  • Medical imaging is commonly used in the clinical practice for cancer screening, early detection and diagnosis of tumors, prediction of cancer prognosis, and assessment of tumor response to treatment [1]

  • We developed and tested a new risk prediction model based on the following scientific evidence or experimental observations: (1) humans naturally show bilateral symmetry in paired morphological traits, including the breasts; (2) bilateral asymmetry of breast tissue patterns is an important imaging phenotype or marker associated to biological processes; (3)

  • In addition to developing computeraided detection or diagnosis (CAD) schemes with machine learning models trained using image features computed from the targeted tumors based on the response evaluation criteria in solid tumors (RECIST) guidelines [42], we investigated and built CAD models and graphic user interface (GUI) to process abdominal computed tomography (CT) images acquired from patients with Epithelial ovarian cancer (EOC) before performing chemotherapy, segment the targeted non-tumor regions, compute image features, and train the machine learning model to predict progression-free survival (PFS) or overall survival (OS) in patients receiving bevacizumabbased chemotherapy

Read more

Summary

Introduction

Medical imaging is commonly used in the clinical practice for cancer screening, early detection and diagnosis of tumors, prediction of cancer prognosis, and assessment of tumor response to treatment [1]. Mammography is the most popular imaging technology used in breast cancer screening, its performance is unsatisfactory in terms of both cancer detection sensitivity and specificity [3]. Studies have shown that sensitivity of screening mammography is lower among younger women (i.e., ≤ 50 years old) [4], those who have dense breasts [5], undergo hormone replacement therapy [6], and carry certain breast cancer susceptibility genes [7]. A high percentage of mammography-occult breast cancer is missed

Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call